Investigating how RNA modifications affect melanoma therapy.
Targeting melanoma promoting RNA modification pathway for melanoma therapy.
This study is looking at how certain changes in RNA affect melanoma cells and their ability to spread and resist treatment, with the goal of finding new ways to boost the immune response and improve treatment for people with melanoma.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11013662 on NIH RePORTER |
What this research studies
This research focuses on understanding how specific RNA modifications influence the behavior of melanoma cells, particularly their ability to spread and resist treatment. By using advanced techniques, researchers will identify RNA-binding proteins that contribute to melanoma metastasis and explore how inhibiting these proteins can enhance the immune response against the cancer. The study aims to uncover new therapeutic targets that could improve treatment outcomes for melanoma patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with melanoma, particularly those with metastatic disease.
Not a fit: Patients with non-melanoma skin cancers or those who are not currently undergoing treatment for melanoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective therapies for melanoma by targeting specific pathways that allow cancer cells to survive and spread.
How similar studies have performed: Previous research has shown promise in targeting RNA modifications for cancer therapy, indicating that this approach may lead to significant advancements in treatment.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Wajapeyee, Narendra — University of Alabama at Birmingham
- Study coordinator: Wajapeyee, Narendra
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.